A victim of changing medical device and drug company business models that have made its small wet laboratory space less relevant, Cincinnati incubator BioStart plans to close on September 30 after 15 years of operations.But president Carol Frankenstein says the BioStart show will go on, albeit in a different form. BioStart as an organization will [...]

Some people see the limitations that are likely to be imposed through the nation’s health care reform efforts, but Carol Frankenstein sees opportunities.

BIOSTART and Queen City Angels have formalized their long-standing relationship through a challenge: Jointly recruit 10 life sciences investors for the angel group within two years.

The life-science incubator BIOSTART has launched an initiative to attract and help about a half-dozen health-care services companies.

BIOSTART has entered into a partnership with YourEncore, which provides management and scientific advice as well as grant-writing help. In addition, BIOSTART in February created Dialedin.org, a life-science portal that lists current events, potential funding opportunities and expert advice.

The state of Indiana used a $2 million to lure PDS Biotechnology, a Cincinnati-based company developing nanoparticle treatments to the immune system to prevent cancer, HPV and several other kinds of infections.